AT
Companies Product search Company name People search
03-09-2010 17:41:10
Search all company information in ?
Change to    


















Danisco a/s

Edit company profile
Langebrogade 1
1001 , København
Denmark
Telephone: 45 3266 2000
http://www.danisco.com
Danisco in brief Danisco is a world leader in food ingredients, enzymes and bio-based solutions. We design and deliver bio-based ingredients that meet market demand for healthier and safer products. Danisco in brief Founded in 1989 Listed on the NASDAQ OMX Nordic Exchange Employees: around 7, 000 (July 2009) Revenue: DKK 12.9 billion (2008/09) International presence: Some 80 locations in more than 40 countries Headquarters: Copenhagen, Denmark Chairman of the Board: Jørgen Tandrup Chief Executive Officer: Tom Knutzen Danisco ingredients are used in about every second ice cream and cheese, every third box of detergent and every fourth loaf of bread produced globally. Danisco’s ingredients are used globally in a wide range of industries – from bakery, dairy...
Key Executives
Contact person CEO Tom Knutzen
Financial Information
Turnover (USD) N/A
Employees N/A
Activity Statement N/A
Brand Name N/A
Date Established N/A
CVR N/A
Keywords
1.  Enzymes
2.  Rare
3.  sugars
4.  Sweeteners
5.  Colours
6.  Antioxidants
7.  Structured lipids
Products and Services
1.   N/A
Related categories
Diät- und Bionahrung
Nahrungsmittel und Getränke - Inhaltsstoffe
DANISCO A/S  company profile      Update Now company Profile
Danisco a/s
Enzymes,

RELATED COMPANIES
Company Name Region
BRDR HONUM A/S DK
BASF HEALTH & NUTRITION A/S DK
Arla Foods DK
BASF HEALTH & NUTRITION A/S DK
DANISCO A/S DK

Latest press news on Enzymes
Xylitol Canada Strategic Partnership Now Includes Mascoma Corporation
2010-09-02T14:30:00
TORONTO, ONTARIO -- (Marketwire) -- 09/02/10 -- Xylitol Canada Inc. ("Xylitol Canada", or the "Co...
Ensign-Bickford Industries, Inc. Acquires Envirologix Inc.
2010-08-30T13:00:00
SIMSBURY, CT -- (Marketwire) -- 08/30/10 -- As part of its business growth and diversification str...
Portola Pharmaceuticals Announces That Phase 2 INNOVATE-PCI Trial With Elinogrel Achieved Objectives
2010-08-30T08:00:00
STOCKHOLM, SWEDEN -- (Marketwire) -- 08/30/10 -- Portola Pharmaceuticals, Inc. today announced re...
 
 Danisco a/s